Rotavirus in Organ Transplantation: Drug-Virus-Host Interactions

YB (Yuebang) Yin, Herold Metselaar, Dave Sprengers, Maikel Peppelenbosch, Qiuwei Pan

Research output: Contribution to journalArticleAcademicpeer-review

29 Citations (Scopus)


Although rotavirus is usually recognized as the most common etiology of diarrhea in young children, it can in fact cause severe diseases in organ transplantation recipients irrespective of pediatric or adult patients. This comprehensive literature analysis revealed 200 cases of rotavirus infection with 8 related deaths in the setting of organ transplantation been recorded. Based on published cohort studies, an average incidence of 3% (187 infections out of 6176 organ recipients) was estimated. Rotavirus infection often causes severe gastroenteritis complications and occasionally contributes to acute cellular rejection in these patients. Immunosuppressive agents, universally used after organ transplantation to prevent organ rejection, conceivably play an important role in such a severe pathogenesis. Interestingly, rotavirus can in turn affect the absorption and metabolism of particular immunosuppressive medications via several distinct mechanisms. Even though rotaviral enteritis is self-limiting in general, infected transplantation patients are usually treated with intensive care, rehydration and replacement of nutrition, as well as applying preventive strategies. This article aims to properly assess the clinical impact of rotavirus infection in the setting of organ transplantation and to disseminate the interactions among the virus, host and immunosuppressive medications. This study reviews the clinical impact of rotavirus infection in the setting of organ transplantation and disseminates the interactions among the virus, host, and immunosuppressive medications.
Original languageUndefined/Unknown
Pages (from-to)585-593
Number of pages9
JournalAmerican Journal of Transplantation
Issue number3
Publication statusPublished - 2015

Cite this